KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Labcorp Holdings (LH) Accounts Payables (2016 - 2025)

Labcorp Holdings (LH) has disclosed Accounts Payables for 17 consecutive years, with $840.8 million as the latest value for Q4 2025.

  • Quarterly Accounts Payables fell 4.0% to $840.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $840.8 million through Dec 2025, down 4.0% year-over-year, with the annual reading at $840.8 million for FY2025, 4.0% down from the prior year.
  • Accounts Payables hit $840.8 million in Q4 2025 for Labcorp Holdings, up from $668.5 million in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $880.7 million in Q1 2023 to a low of $599.9 million in Q2 2021.
  • Historically, Accounts Payables has averaged $731.6 million across 5 years, with a median of $715.5 million in 2023.
  • Biggest five-year swings in Accounts Payables: surged 41.23% in 2023 and later decreased 21.03% in 2024.
  • Year by year, Accounts Payables stood at $621.3 million in 2021, then surged by 37.16% to $852.2 million in 2022, then decreased by 2.9% to $827.5 million in 2023, then increased by 5.84% to $875.8 million in 2024, then decreased by 4.0% to $840.8 million in 2025.
  • Business Quant data shows Accounts Payables for LH at $840.8 million in Q4 2025, $668.5 million in Q3 2025, and $793.0 million in Q2 2025.